French authorities investigate Sanofi over market manipulation, misleading financial communications
A source inside France’s National Financial Prosecutor’s Office confirmed to Endpoints News on Tuesday that it initiated a preliminary investigation into French drugmaker Sanofi over potential stock price manipulation and the dissemination of misleading or false financial communications.
The probe that began last March, the details of which have not been made public but were first reported last night by the French media outlet La Lettre, is also news to Sanofi.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.